The WACC of USANA Health Sciences Inc (USNA) is 8.1%.
Range | Selected | |
Cost of equity | 7.1% - 9.4% | 8.25% |
Tax rate | 34.4% - 36.8% | 35.6% |
Cost of debt | 4.5% - 4.5% | 4.5% |
WACC | 7.0% - 9.2% | 8.1% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.71 | 0.81 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.1% | 9.4% |
Tax rate | 34.4% | 36.8% |
Debt/Equity ratio | 0.04 | 0.04 |
Cost of debt | 4.5% | 4.5% |
After-tax WACC | 7.0% | 9.2% |
Selected WACC | 8.1% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
USNA | USANA Health Sciences Inc | 0.04 | 0.91 | 0.89 |
ELF | e.l.f. Beauty Inc | 0.06 | 1.58 | 1.52 |
EPC | Edgewell Personal Care Co | 0.93 | 0.48 | 0.3 |
IPAR | Inter Parfums Inc | 0.04 | 0.89 | 0.87 |
JWEL.TO | Jamieson Wellness Inc | 0.3 | 0.58 | 0.49 |
MTEX | Mannatech Inc | 0.2 | 0.73 | 0.65 |
NAII | Natural Alternatives International Inc | 0.63 | -0.12 | -0.09 |
REV | Revlon Inc | 3.53 | 1.93 | 0.59 |
SUMR | Summer Infant Inc | 1.52 | 1.53 | 0.78 |
VERU | Veru Inc | 0.13 | 0.47 | 0.43 |
Low | High | |
Unlevered beta | 0.55 | 0.7 |
Relevered beta | 0.57 | 0.72 |
Adjusted relevered beta | 0.71 | 0.81 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for USNA:
cost_of_equity (8.25%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.71) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.